Neuraxial plus general anesthesia may improve prostate CA outcomes

This article originally appeared here.
Share this content:
Neuraxial + General Anesthesia May Up Prostate CA Outcomes
Neuraxial + General Anesthesia May Up Prostate CA Outcomes

(HealthDay News) -- Supplementing general anesthesia (GA) with neuraxial anesthesia during prostate cancer surgery is associated with improved oncological outcomes compared with GA alone, according to a study published online Dec. 16 in the British Journal of Anaesthesia.

Federica Scavonetto, M.D., from the Mayo Clinic in Rochester, Minn., and colleagues reviewed medical records from 1,642 patients with prostate cancer who had GA with neuraxial analgesia, matched in a 1:1 ratio with controls who had GA alone, based on age, surgical year, pathological stage, Gleason scores, and presence of lymph node disease. Participants were followed for a median of nine years.

The researchers found that GA alone correlated with significantly increased risk for systemic progression (hazard ratio, 2.81; P = 0.008) and elevated overall mortality (hazard ratio, 1.32; P = 0.047), after adjustment for comorbidities, positive surgical margins, and adjuvant hormonal and radiation therapies within 90 postoperative days. Similar findings were observed for the outcome of prostate cancer deaths, although the association was not significant (adjusted hazard ratio, 2.2; P = 0.091).

"This large retrospective analysis suggests a possible beneficial effect of regional anesthetic techniques on oncological outcomes after prostate surgery for cancer; however, these findings need to be confirmed (or refuted) in randomized trials," the authors conclude.

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs